THE RETATRUTIDE DIARIES

Semaglutide has long been proven to result in medullary thyroid mobile carcinoma in rodents. Though its medical relevance to people is unidentified, the FDA advises never to administer this drug in Those people with a private or spouse and children record of medullary thyroid carcinoma. Semaglutide also poses a possibility of pancreatitis and dehyd